Skip to main content
NIH funding notice RFA-AG-25-004

Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required)

Closed on October 10, 2024.

Posted
April 24, 2024
Close date
October 10, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$3,399,999
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF COLORADO DENVER1

Most frequent study sections

  1. Special Emphasis Panel (ZAG1 ZIJ-5 (M1))1
1 award under RFA-AG-25-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2025Psychedelics for Older Adults with Chronic Pain1UG3AG094957-01Fischer, Stacy MMitchell, Jennifer M.Ross, StephenUNIVERSITY OF COLORADO DENVER, COFirst-year cost $3,399,999Study section ZAG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-AG-25-004: Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required) | ScienceDex | ConductScience